BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6269777)

  • 1. Effect of EHDP on calcium accumulation and technetium-99m pyrophosphate uptake in experimental myocardial infarction.
    Buja LM; Tofe AJ; Parkey RW; Francis MD; Lewis SE; Kulkarni PV; Bonte FJ; Willerson JT
    Circulation; 1981 Nov; 64(5):1012-7. PubMed ID: 6269777
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial imaging in myocardial infarction: technetium vs. thallium.
    Gerson MC
    Cardiovasc Clin; 1983; 13(3):223-42. PubMed ID: 6309389
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
    Williams CC; Nishiyama H; Adolph RJ; Romhilt DW; Sodd VJ; Saenger EL; Gabel M
    J Nucl Med; 1977 Sep; 18(9):905-9. PubMed ID: 197134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m pyrophosphate myocardial imaging in perimyocarditis.
    Ahmad M; Dubiel JP
    J Nucl Med; 1981 May; 22(5):452-4. PubMed ID: 6260911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m pyrophosphate myocardial imaging in acute myocardial infarction: value and limitations.
    Ahmad M
    Mo Med; 1981 Sep; 78(9):575-8. PubMed ID: 6273708
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial uptake of technetium-99m pyrophosphate in systemic amyloidosis.
    Ptacin MJ
    Am J Cardiol; 1984 Oct; 54(7):938-9. PubMed ID: 6091435
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
    Fogelman I; Bessent RG
    Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of persistently positive technetium-99m pyrophosphate myocardial scintigrams in patients with acute myocardial infarction].
    Nakashima Y; Fukuzaki H; Maeda K; Minamiji K; Kida T; Yoshida Y
    Kaku Igaku; 1984 Mar; 21(3):221-9. PubMed ID: 6088866
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of myocardial necrosis immediately after intracoronary thrombolysis by intracoronary injection of technetium-99m pyrophosphate.
    Schofer J; Stritzke P; Montz R; Mathey DG
    Eur Heart J; 1984 Aug; 5(8):617-21. PubMed ID: 6090146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m-pyrophosphate accumulation on prosthetic valves.
    Seo I; Donoghue G
    Clin Nucl Med; 1980 Aug; 5(8):367-9. PubMed ID: 6249532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technetium-99m pyrophosphate scintigraphy in acute myocardial infarction with special reference to the detection of high risk cases].
    Nakashima Y; Fukuzaki H; Maeda K; Minamiji K; Kida T; Okada T; Imai N; Yamada S; Goto T; Yoshida Y
    Kaku Igaku; 1984 Jan; 21(1):27-33. PubMed ID: 6330408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial necrosis in chronic course of ischemic heart disease].
    Sycheva IM; Vinogradov AV; Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Kardiologiia; 1990 Sep; 30(9):9-12. PubMed ID: 2177126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical nuclear cardiology: 1. Studies of myocardial perfusion and cellular damage.
    Huckell VF; Stewart MA
    CMAJ; 1987 Feb; 136(4):335-43. PubMed ID: 3028592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
    Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
    J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases.
    Shigeno C; Fukunaga M; Yamamoto I; Dokoh S; Morita R; Hino M; Torizuka K
    Clin Nucl Med; 1982 Jun; 7(6):297-8. PubMed ID: 6282522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of pyrophosphate and gluconate scans of the heart in dogs with experimental cardiomyopathy].
    Duska F; Novák J; Kafka P; Kubícek J; Vizd'a J; Mazurová Y; Veverková O
    Vnitr Lek; 1983 Apr; 29(4):338-44. PubMed ID: 6306923
    [No Abstract]   [Full Text] [Related]  

  • 19. Radionuclide assessment of myocardial injury in a heterotopic rat heart transplant model.
    McGregor CG; Hannan WJ; Wheatley DJ; Smith AF; Muir AL
    Int J Nucl Med Biol; 1984; 11(2):189-94. PubMed ID: 6090331
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical reliability and limitation of 99m Tc-pyrophosphate myocardial scintigraphy for the assessment of acute myocardial infarction--with special reference to evaluation of the area affected by infarction].
    Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Hishida H; Mizuno Y; Ejiri K; Kawai K; Takeuchi A; Koga S
    Kaku Igaku; 1982 Jul; 19(6):871-9. PubMed ID: 6296506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.